No Data
Johnson & Johnson Aims New Policy For Hospital Payments Under 340B Drug Discount Program Related To Its Flagship Blood Thinner And Arthritis Drugs
Johnson & Johnson Seeks Resolution With Plaintiffs, Pushes To Finalize $6.5B Talc Settlement
J&J (JNJ) Gets EU Approval for Bladder Cancer Drug Balversa
Express News | J&J - Mulholland Will Also Be Appointed as a Member of Johnson & Johnson's Executive Committee, Effective October 1, 2024
Express News | Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024
Market Chatter: Johnson & Johnson Negotiates With Opposing Lawyers on $6.48 Billion Talc Settlement
103916021 : k
山芭佬 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)